Proper Dosage of Ketamine in Intravenous Regional Anesthesia
Status:
Unknown status
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
Ketamine added to Lidocaine can increase duration of pain relief following intraveonous
regional anesthesia (IVRA). The purpose of this dose response study is to determine the
minimum effective dosage of intravenous Ketamine, added to 3 mg/kg of Lidocaine. We
anticipate that one dosage will provide us with the proper balance between sufficient
anesthesia and minimal side effects.